$Progenity, Inc.(PROG)$ short squeeze candidate with strong fundamentals and great catalysts ahead, possible GI tract disease patent PR , high short interest and utilization, possible buyout coming out anytime this year, and a conference on the 29th of October where a huge pharmaceutical partnership could be announced…if you aren’t buying PROG wtf are you doing?
精彩评论